CD8A and autoimmune disease: Recently, Zhao et al. showed that the depletion of PD-1+ cells may ameliorate autoimmune disease in different mouse models [34], but the manageable selectivity of treatment for CD8+ vs. CD4+ T cells should be carefully investigated.